Search Results
Oct 13, 2025, 09:40 ET Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market
patients worldwide. By combining Yike's cutting-edge regenerative science with GV's global commercialization capabilities, we aim to deliver transformative medical solutions to patients worldwide. We are confident that this collaboration will not only generate meaningful health
More news about: Visionary Holdings Inc.
Oct 13, 2025, 09:20 ET Jiuzi Holdings, Inc. (JZXN) Secures 100 Bitcoin via Private Placement, Signaling New Phase in Crypto Treasury Deployment
constructing an intelligent digital asset custody platform, and developing cutting-edge technology-based encrypted storage systems. These initiatives aim to strengthen the Company's infrastructure service capabilities in the digital economy era. Since the disclosure of the transaction
More news about: Jiuzi Holdings, Inc
Oct 13, 2025, 09:20 ET Jiuzi Holdings, Inc. (JZXN) Secures 100 Bitcoin via Private Placement, Signaling New Phase in Crypto Treasury Deployment
an intelligent digital asset custody platform, and developing cutting-edge technology-based encrypted storage systems. These initiatives aim to strengthen the Company's infrastructure service capabilities in the digital economy era. Since the disclosure of the transaction
More news about: Jiuzi Holdings, Inc
Oct 13, 2025, 09:14 ET Canaan Inc. Launches Innovative Gas-to-Computing Pilot in Canada with Energy Infrastructure Developer
and economic viability of wellhead power generation for bitcoin mining and other high-density computing applications, Canaan and Aurora aim to establish a repeatable model that expands global computing capacity while improving the efficiency and sustainability of energy utilization.
More news about: Canaan Inc.
Oct 13, 2025, 09:01 ET Oracle Joins The Smart Factory by Deloitte @ Wichita to Accelerate AI and Automation in Manufacturing
The Smart Factory by Deloitte @ Wichita. By co-innovating at The Factory, Deloitte and Oracle aim to help manufacturers and industrial organizations integrate artificial intelligence (AI) and automation into their operations, while streamlining data
More news about: Deloitte
Oct 13, 2025, 09:00 ET Barilla Brings Domenica Italiana to Austin During Formula 1 MSC Cruises United States Grand Prix 2025 Weekend
nutrition, inspired by the Mediterranean Diet and the Italian lifestyle. When Pietro opened his shop over 145 years ago, the main aim was to make good food. That principle has now become the Barilla way of doing business, with almost 9,000 people working for the company and a supply
More news about: Barilla America, Inc.
Oct 13, 2025, 09:00 ET GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
education, collaboration, and supporting clinicians in delivering high-quality patient care," said Strasters. "Through initiatives like our IIR program, we aim to empower healthcare professionals and investigators to drive the next wave of insights in the treatment of primary immunodeficiencies."
More news about: GC Biopharma USA Inc.
Oct 13, 2025, 08:54 ET Sail4th 250 and America250 Announce Historic Partnership to Honor America's 250th Anniversary
mission is to celebrate and commemorate the 250th anniversary of the signing of the Declaration of Independence, marking America's Semiquincentennial. We aim to inspire our fellow Americans to reflect on our past, strengthen our love of country, and renew our commitment to the ideals of democracy through programs
More news about: Sail4th 250
Oct 13, 2025, 08:28 ET Zeta Surgical® AI-powered TMS Navigation System Receives FDA 510(k) Clearance
shown in research to significantly improve treatment efficacy," said Jose Maria Amich, Co‑Founder and Chief Executive Officer of Zeta Surgical. "Our aim is to make stereotactic-grade, high‑accuracy image guidance practical in everyday neuromodulation workflows." About Zeta Surgical
More news about: Zeta Surgical
Oct 13, 2025, 08:00 ET YY Group Launches Bursary Award for Gig Workers Pursuing Higher Education
condition. In some cases, forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. All information provided in this
More news about: YY Group Holding Limited
Oct 13, 2025, 08:00 ET U Power Reports Unaudited Financial Results for the First Half of 2025
financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "could," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "propose," "potential," "continue" or similar expressions. The Company undertakes no obligation
More news about: U Power Limited
Oct 13, 2025, 06:30 ET Bright Scholar Enters into Definitive Agreement for Going-Private Transaction
without limitation, the Company's business plans and development, which can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "future," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Bright Scholar may also
More news about: Bright Scholar Education Holdings Limited
Oct 13, 2025, 06:03 ET Taylor Morrison Recognized in U.S. News & World Report's 2025-2026 Best Companies to Work For List for Third Consecutive Year
2025-2026 Best Companies to Work For list by U.S. News & World Report, the global authority in rankings and consumer advice. The ratings aim to help employees and job seekers identify workplaces that align with their values and needs.
More news about: Taylor Morrison
Oct 13, 2025, 06:00 ET ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease
with serious neurogenetic diseases worldwide. ReviR was founded in 2021 by leaders in computational biology, RNA biology, and drug discovery, with the aim to create disease-modifying therapies that are highly specific, efficacious, and safe. ReviR's lead candidate, RTX-117, is an investigational small molecule
More news about: ReviR Therapeutics
Oct 13, 2025, 05:13 ET EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology
platform that helps standardize and improve customer engagement, regulatory compliance and accelerate clinical trial execution. The combined capabilities aim to help life sciences organizations harness artificial intelligence (AI) and enterprise data more effectively across their value chain.
More news about: EY
Oct 13, 2025, 05:12 ET EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology
platform that helps standardize and improve customer engagement, regulatory compliance and accelerate clinical trial execution. The combined capabilities aim to help life sciences organizations harness artificial intelligence (AI) and enterprise data more effectively across their value chain.
More news about: EY
Oct 13, 2025, 04:49 ET AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025
and innovative drug candidates, and collaborating with global pharmaceutical partners. Upon achieving proof-of-concept in phase II clinical trials, we aim to out-license our products for further co-development and commercialization, with the goal of bringing them to global markets and driving sustainable
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 13, 2025, 04:40 ET Building-to-Grid Technology Market to Reach $147.8 billion, Globally, by 2034 at 10.5% CAGR: Allied Market Research
technology is increasingly becoming a cornerstone of smart city development, fundamentally transforming how urban energy systems operate. Smart cities aim to integrate information and communication technologies to improve the quality of life, sustainability, and efficiency of urban environments. Within
More news about: Allied Market Research
Oct 13, 2025, 03:16 ET LG SHOWCASES PUROTEC™ ANTIMICROBIAL MATERIAL AT K SHOW IN GERMANY
Company. "By strengthening collaborations with global partners, reinforcing compliance with international standards and delivering reliable performance, we aim to establish PuroTec as a core pillar of LG's materials business – driving sustainable growth and strengthening our leadership in the global market."
More news about: LG Electronics, Inc.
Oct 13, 2025, 03:06 ET AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025
and innovative drug candidates, and collaborating with global pharmaceutical partners. Upon achieving proof-of-concept in phase II clinical trials, we aim to out-license our products for further co-development and commercialization, with the goal of bringing them to global markets and driving sustainable
More news about: AnnJi Pharmaceutical Co., Ltd.
Oct 13, 2025, 03:00 ET A Landmark Partnership: HAVIT Partners with Three Top International Esports Teams to Expand Global Presence
crucial implementation of HAVIT's 'For Fun. For Games. For Champions' vision,'' said Yao, brand director at HAVIT. "By merging technology with esports, we aim to inspire gamers worldwide to break boundaries and shape the future of gaming." Meet HAVIT at Global Trade
More news about: GUANGZHOU HAVIT TECHNOLOGY CO., LTD.
Oct 13, 2025, 02:05 ET Public Policy Holding Company, Inc. ("PPHC", the "Group" or the "Company") Notification of Registration Statement Filing PPHC Files for Proposed U.S. IPO, Nasdaq Listing
U.S. offering and listing, PPHC's shares will be dual-listed on Nasdaq and on the Alternative Investment Market of the London Stock Exchange ("AIM"), where they trade under the same symbol. It is anticipated that the shares will be fully fungible. The number of shares
More news about: Public Policy Holding Company
Oct 13, 2025, 02:05 ET Public Policy Holding Company, Inc. ("PPHC", the "Group" or the "Company") Notification of Registration Statement Filing PPHC Files for Proposed U.S. IPO, Nasdaq Listing
U.S. offering and listing, PPHC's shares will be dual-listed on Nasdaq and on the Alternative Investment Market of the London Stock Exchange ("AIM"), where they trade under the same symbol. It is anticipated that the shares will be fully fungible. The
More news about: Public Policy Holding Company
Oct 11, 2025, 11:45 ET LI-NING Welcomes Egor Dëmin to the Way of Wade Athlete Roster
Macau, China, on Saturday night. It was attended by 150 media and influencers. "As we continue to expand our brand internationally, we aim to partner with athletes who embody the 'Anything is Possible' spirit upon which our brand was founded," said Mr. Li Ning. "Egor Dëmin
More news about: LI-NING
Oct 11, 2025, 09:30 ET PEOPLE WHO RECEIVE LESS SEDATION WHEN VENTILATOR-DEPENDENT MORE LIKELY TO RETURN TO INDEPENDENT LIVING AFTER HOSPITALIZATION
Deep sedation - when medications keep patients from being fully conscious and not easily aroused - is commonly used in ICUs across the country with the aim of preventing ventilated patients from experiencing emotional distress and/or pain during their critical recovery. Since the COVID-19 pandemic, the use
More news about: Montefiore Health System